Dynamic Assay for Profiling Anti-SARS-CoV-2 Antibodies and Their ACE2/Spike RBD Neutralization Capacity

Serological assays have been widely employed during the coronavirus disease 2019 (COVID-19) pandemic to measure antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to track seroconversion in populations. However, currently available assays do not allow determinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Phelan, Thomas, Dunne, Jean, Conlon, Niall, Cheallaigh, Clíona Ní, Abbott, W. Mark, Faba-Rodriguez, Raquel, Amanat, Fatima, Krammer, Florian, Little, Mark A., Hughes, Gerry, Bergin, Colm, Kerr, Colm, Sundaresan, Sudharshana, Long, Aideen, McCormack, William, Brady, Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309970/
https://www.ncbi.nlm.nih.gov/pubmed/34372581
http://dx.doi.org/10.3390/v13071371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309970/
https://www.ncbi.nlm.nih.gov/pubmed/34372581
http://dx.doi.org/10.3390/v13071371

Ejemplares similares